TY - JOUR
T1 - Surgonomics
T2 - Health Care Financing Policy for Hospitalized Otolaryngology Patients
AU - Muñoz, Eric
AU - Zahtz, Gerald
AU - Goldstein, Jonathan
AU - Benacquista, Theresa
AU - Mulloy, Katherine
AU - Wise, Leslie
PY - 1988/11
Y1 - 1988/11
N2 - • The Medicare diagnosis related group (DRG) prospective payment model is changing hospital payment. Currently many states are using DRG prospective "All Payor Systems" for hospital reimbursement. In All Payor Systems, Medicare, Medicaid, Blue Cross, and other commercial insurers pay by the DRG mode; New York State has been All Payor since Jan 1, 1988. This study simulated DRG All Payor methods on a large sample (N=1074) of adult otolaryngology patients for a two-year period using both federal and New York DRG reimbursement now in effect. Both Medicare and Medicaid patients had (on average) a longer hospital stay and total hospital cost compared with patients from Blue Cross and other commercial payors. Medicare and Medicaid patients also had a greater severity of illness compared with patients from Blue Cross or other payors. All payors (ie, Medicaid, Blue Cross, and commercial insurers), except Medicare, generated financial risk under the DRG All Payor scheme. These data suggest that state and private payors may be underreimbursing for the care of the hospitalized otolaryngology patient using the DRG prospective hospital payment scheme. Health care financing policy described in this study may limit both the access and/or the quality of care for many otolaryngology patients in the future. (Arch Otolaryngol Head Neck Surg 1988;114:1317-1320)
AB - • The Medicare diagnosis related group (DRG) prospective payment model is changing hospital payment. Currently many states are using DRG prospective "All Payor Systems" for hospital reimbursement. In All Payor Systems, Medicare, Medicaid, Blue Cross, and other commercial insurers pay by the DRG mode; New York State has been All Payor since Jan 1, 1988. This study simulated DRG All Payor methods on a large sample (N=1074) of adult otolaryngology patients for a two-year period using both federal and New York DRG reimbursement now in effect. Both Medicare and Medicaid patients had (on average) a longer hospital stay and total hospital cost compared with patients from Blue Cross and other commercial payors. Medicare and Medicaid patients also had a greater severity of illness compared with patients from Blue Cross or other payors. All payors (ie, Medicaid, Blue Cross, and commercial insurers), except Medicare, generated financial risk under the DRG All Payor scheme. These data suggest that state and private payors may be underreimbursing for the care of the hospitalized otolaryngology patient using the DRG prospective hospital payment scheme. Health care financing policy described in this study may limit both the access and/or the quality of care for many otolaryngology patients in the future. (Arch Otolaryngol Head Neck Surg 1988;114:1317-1320)
UR - http://www.scopus.com/inward/record.url?scp=0023734461&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023734461&partnerID=8YFLogxK
U2 - 10.1001/archotol.1988.01860230111037
DO - 10.1001/archotol.1988.01860230111037
M3 - Article
C2 - 3139014
AN - SCOPUS:0023734461
SN - 0886-4470
VL - 114
SP - 1317
EP - 1320
JO - Archives of Otolaryngology - Head and Neck Surgery
JF - Archives of Otolaryngology - Head and Neck Surgery
IS - 11
ER -